| Name | Title | Contact Details |
|---|---|---|
Tony Handzic-Smith |
Vice President, Global Supply Chain Planning and Network Strategy | Profile |
Talitha Hampton |
Senior Director, Global Supply Chain and Strategic Sourcing | Profile |
Ashvin Patel |
Associate Director Revenue and OTC | Profile |
Ali Rahman |
Director, External Drug Product Manufacturing Operations at NOVAVAX | Profile |
Bibin Abraham |
Head of HR Technology and Analytics | Profile |
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
BioTek Instruments is a worldwide leader in the development of high performance, bioanalytical measurement systems and software. Our representatives worldwide call on a variety of customers including academic, government, and biotech/pharmaceutical. We
Nohla Therapeutics is a cellular therapy company driven to provide leading off the shelf therapies for patients with critical diseases. Nohla’s first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy induced neutropenia, and is being extended to treat a range of other medical indications. This and other products in the pipeline are based on a unique umbilical cord blood expansion platform developed at the Fred Hutchinson Cancer Research Center
Mcnan Technologies Inc is a Glen Allen, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases. Our founders` groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source.